Alpna Seth's most recent trade in Keros Therapeutics Inc was a trade of 10,500 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 4, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Keros Therapeutics Inc | Alpna Seth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 10,500 | 10,500 | - | - | Stock Option (right to buy) | |
| Keros Therapeutics Inc | Alpna Seth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 5,250 | 5,250 | - | 0 | Common Stock | |
| Bio-Techne | Alpna Seth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Oct 2024 | 3,511 | 3,511 | - | - | Stock Options (Right to Buy) | |
| Bio-Techne | Alpna Seth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Oct 2024 | 1,462 | 13,771 (0%) | 0% | 0 | Common Stock | |
| Keros Therapeutics Inc | Alpna Seth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| Keros Therapeutics Inc | Alpna Seth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| Seagen Inc | Alpna Seth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 2,044 | 14,997 (0%) | 0% | 0 | Common Stock | |
| Keros Therapeutics Inc | Alpna Seth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2023 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Bio-Techne | Alpna Seth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2022 | 865 | 865 | - | - | Stock Options (Right to Buy) | |
| Bio-Techne | Alpna Seth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2022 | 338 | 2,671 (0%) | 0% | 0 | Common Stock | |
| Seagen Inc | Alpna Seth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2022 | 3,676 | 3,676 | - | - | Non-Qualified Stock Option (right to buy) | |
| Seagen Inc | Alpna Seth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2022 | 1,503 | 12,953 (0%) | 0% | 0 | Common Stock | |
| Bio-Techne | Alpna Seth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Oct 2021 | 633 | 633 | - | - | Stock Option (right to buy) | |
| Bio-Techne | Alpna Seth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Oct 2021 | 194 | 2,333 (0%) | 0% | 0 | Common Stock | |
| Seagen Inc | Alpna Seth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2021 | 3,462 | 3,462 | - | - | Non-Qualified Stock Option (right to buy) | |
| Seagen Inc | Alpna Seth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2021 | 1,402 | 11,450 (0%) | 0% | 0 | Common Stock | |
| Bio-Techne | Alpna Seth | Director | Sale of securities on an exchange or to another person at price $ 306.95 per share. | 09 Nov 2020 | 3,665 | 2,139 (0%) | 0% | 307.0 | 1,124,972 | Common Stock |
| Bio-Techne | Alpna Seth | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Nov 2020 | 3,125 | 0 | - | - | Stock Option (Right to Buy) | |
| Bio-Techne | Alpna Seth | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 125.05 per share. | 09 Nov 2020 | 3,125 | 7,162 (0%) | 0% | 125.0 | 390,781 | Common Stock |
| Bio-Techne | Alpna Seth | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Nov 2020 | 1,898 | 0 | - | - | Stock Option (Right to Buy) | |
| Bio-Techne | Alpna Seth | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 179.84 per share. | 09 Nov 2020 | 1,898 | 4,037 (0%) | 0% | 179.8 | 341,336 | Common Stock |
| Bio-Techne | Alpna Seth | Director | Sale of securities on an exchange or to another person at price $ 305.74 per share. | 09 Nov 2020 | 1,358 | 5,804 (0%) | 0% | 305.7 | 415,195 | Common Stock |
| Bio-Techne | Alpna Seth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Oct 2020 | 1,507 | 1,507 | - | - | Stock Option (Right to Buy) | |
| Bio-Techne | Alpna Seth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Oct 2020 | 391 | 2,139 (0%) | 0% | 0 | Common Stock |